128 related articles for article (PubMed ID: 3957409)
1. Unusual complement activation properties of serum immunoglobulins of the pigeon Columba livia.
Koppenheffer TL; Russell BA
Immunology; 1986 Mar; 57(3):473-8. PubMed ID: 3957409
[TBL] [Abstract][Full Text] [Related]
2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
[TBL] [Abstract][Full Text] [Related]
4. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
Knutzen Steuer KL; Sloan LB; Oglesby TJ; Farries TC; Nickells MW; Densen P; Harley JB; Atkinson JP
J Immunol; 1989 Oct; 143(7):2256-61. PubMed ID: 2506280
[TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative pathway of complement by antiserum to factor B.
Wilson MR; Arroyave CM; Tan EM
J Lab Clin Med; 1979 Mar; 93(3):493-8. PubMed ID: 107255
[TBL] [Abstract][Full Text] [Related]
6. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
[TBL] [Abstract][Full Text] [Related]
7. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
[TBL] [Abstract][Full Text] [Related]
8. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
Miletic VD; Hester CG; Frank MM
J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
[TBL] [Abstract][Full Text] [Related]
9. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
Ohta H; Yoshikawa Y; Kai C; Yamanouchi K; Okada H
Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
11. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
[TBL] [Abstract][Full Text] [Related]
12. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
Czop JK; Austen KF
J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
[TBL] [Abstract][Full Text] [Related]
13. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
Doekes G; van Es LA; Daha MR
J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
[TBL] [Abstract][Full Text] [Related]
14. Biological properties of chimeric antibodies. Interaction with complement.
Boulianne GL; Isenman DE; Hozumi N; Shulman MJ
Mol Biol Med; 1987 Feb; 4(1):37-49. PubMed ID: 3613975
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of organic solvents on immunity indicators in serum.
Stefanovic J; Starsia Z; Murgasová I; Absolonová O
J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
[TBL] [Abstract][Full Text] [Related]
16. Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation.
Polhill RB; Newman SL; Pruitt KM; Johnston RB
J Immunol; 1978 Jul; 121(1):371-6. PubMed ID: 670706
[TBL] [Abstract][Full Text] [Related]
17. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
Loos M; Thesen R
J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
[TBL] [Abstract][Full Text] [Related]
18. Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.
Gadd KJ; Reid KB
Immunology; 1981 Jan; 42(1):75-82. PubMed ID: 6780451
[TBL] [Abstract][Full Text] [Related]
19. Activation of the classical pathway of human complement by a human monoclonal IgE, IgE(DES).
Saint-Remy JM; Magnusson CG; Masson PL
J Immunol; 1983 Mar; 130(3):1341-4. PubMed ID: 6822738
[TBL] [Abstract][Full Text] [Related]
20. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
